# Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

> **NCT03056053** · PHASE2 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 113 (actual)

## Conditions studied

- Insomnia Disorder

## Interventions

- **DRUG:** Zolpidem

## Key facts

- **NCT ID:** NCT03056053
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2017-04-21
- **Final completion:** 2017-05-05
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03056053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03056053, "Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03056053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*